Skip to main content
Premium Trial:

Request an Annual Quote

WaferGen SmartChip System to be Used in Wound Drug Research

NEW YORK (GenomeWeb News) – WaferGen Biosystems said today that its SmartChip Real-Time PCR System will be used in preclinical and clinical studies of ImmuneRegen's wound-healing drug candidate Homspera.

The studies will be carried out by researchers at the University of Texas Southwestern Medical Center. They will use the SmartChip system to validate relevant gene expression biomarkers and to assess their impact on patient response to treatment.

"We expect this collaboration to provide a clear demonstration of the value that the SmartChip system can offer in the area of drug discovery and development, particularly as it pertains to harnessing the potential of biomarkers," Alnoor Shivji, chairman and CEO of WaferGen, said in a statement.

Fremont, Calif.-based WaferGen and UT Southwestern are already collaborating on a study to identify and validate biomarkers related to wound healing, and they also will study the impact of those biomarkers on patient response to treatment. That pact is separate from the one announced today.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.